1218 related articles for article (PubMed ID: 24939927)
21. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
[TBL] [Abstract][Full Text] [Related]
22. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
Bangalore S; Toklu B; Amoroso N; Fusaro M; Kumar S; Hannan EL; Faxon DP; Feit F
BMJ; 2013 Nov; 347():f6625. PubMed ID: 24212107
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis.
Siontis GC; Stefanini GG; Mavridis D; Siontis KC; Alfonso F; Pérez-Vizcayno MJ; Byrne RA; Kastrati A; Meier B; Salanti G; Jüni P; Windecker S
Lancet; 2015 Aug; 386(9994):655-64. PubMed ID: 26334160
[TBL] [Abstract][Full Text] [Related]
25. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
[TBL] [Abstract][Full Text] [Related]
26. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
27. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
28. Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.
Aronson D; Edelman ER
Rev Endocr Metab Disord; 2010 Mar; 11(1):75-86. PubMed ID: 20221852
[TBL] [Abstract][Full Text] [Related]
29. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
[TBL] [Abstract][Full Text] [Related]
30. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of various percutaneous interventions for in-stent restenosis: comprehensive network meta-analysis of randomized controlled trials.
Sethi A; Malhotra G; Singh S; Singh PP; Khosla S
Circ Cardiovasc Interv; 2015 Nov; 8(11):e002778. PubMed ID: 26546577
[TBL] [Abstract][Full Text] [Related]
32. Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials.
Cassese S; Piccolo R; Galasso G; De Rosa R; Piscione F
Int J Cardiol; 2011 Jul; 150(1):84-9. PubMed ID: 21315461
[TBL] [Abstract][Full Text] [Related]
33. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
34. Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.
De Luca G; Schaffer A; Verdoia M; Suryapranata H
Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):344-54. PubMed ID: 24373711
[TBL] [Abstract][Full Text] [Related]
35. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.
Kim H; Kang DY; Ahn JM; Lee J; Choi Y; Hur SH; Park HJ; Tresukosol D; Kang WC; Kwon HM; Rha SW; Lim DS; Jeong MH; Lee BK; Huang H; Lim YH; Bae JH; Kim BO; Ong TK; Ahn SG; Chung CH; Park DW; Park SJ;
JACC Cardiovasc Interv; 2023 Oct; 16(19):2412-2422. PubMed ID: 37821187
[TBL] [Abstract][Full Text] [Related]
36. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
37. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
[TBL] [Abstract][Full Text] [Related]
38. Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.
Kereiakes DJ; Sudhir K; Hermiller JB; Gordon PC; Ferguson J; Yaqub M; Sood P; Su X; Yakubov S; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2010 Dec; 3(12):1229-39. PubMed ID: 21232716
[TBL] [Abstract][Full Text] [Related]
39. Diabetes and coronary revascularization.
Flaherty JD; Davidson CJ
JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875
[TBL] [Abstract][Full Text] [Related]
40. Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Valgimigli M; Sabaté M; Kaiser C; Brugaletta S; de la Torre Hernandez JM; Galatius S; Cequier A; Eberli F; de Belder A; Serruys PW; Ferrante G
BMJ; 2014 Nov; 349():g6427. PubMed ID: 25378023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
